Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1118

1.

Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.

Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.

Pediatr Transplant. 2004 Jun;8(3):267-72.

PMID:
15176965
[PubMed - indexed for MEDLINE]
2.

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

McDiarmid SV, Jordan S, Kim GS, Toyoda M, Goss JA, Vargas JH, Martín MG, Bahar R, Maxfield AL, Ament ME, Busuttil RW.

Transplantation. 1998 Dec 27;66(12):1604-11. Erratum in: Transplantation 1999 Sep 27;68(6):909. Lee GS [corrected to Kim GS].

PMID:
9884246
[PubMed - indexed for MEDLINE]
3.

Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.

Cacciarelli TV, Green M, Jaffe R, Mazariegos GV, Jain A, Fung JJ, Reyes J.

Transplantation. 1998 Oct 27;66(8):1047-52.

PMID:
9808490
[PubMed - indexed for MEDLINE]
4.

Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients.

Ganschow R, Schulz T, Meyer T, Broering DC, Burdelski M.

J Pediatr Gastroenterol Nutr. 2004 Feb;38(2):198-203.

PMID:
14734884
[PubMed - indexed for MEDLINE]
5.

Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.

Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J Jr, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.

J Heart Lung Transplant. 1998 Dec;17(12):1161-6.

PMID:
9883755
[PubMed - indexed for MEDLINE]
6.

Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.

Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.

Pediatr Transplant. 2009 Feb;13(1):54-62. doi: 10.1111/j.1399-3046.2008.00969.x. Epub 2008 Jun 1.

PMID:
18518912
[PubMed - indexed for MEDLINE]
7.

Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.

Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO.

Pediatr Transplant. 1999 Feb;3(1):22-6.

PMID:
10359027
[PubMed - indexed for MEDLINE]
8.

Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.

Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.

J Clin Oncol. 2005 Sep 20;23(27):6481-8.

PMID:
16170157
[PubMed - indexed for MEDLINE]
Free Article
9.

Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.

Sokal EM, Antunes H, Beguin C, Bodeus M, Wallemacq P, de Ville de Goyet J, Reding R, Janssen M, Buts JP, Otte JB.

Transplantation. 1997 Nov 27;64(10):1438-42.

PMID:
9392308
[PubMed - indexed for MEDLINE]
10.

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.

J Heart Lung Transplant. 2008 Jan;27(1):100-5. doi: 10.1016/j.healun.2007.09.027.

PMID:
18187094
[PubMed - indexed for MEDLINE]
11.

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.

Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, Woodle ES, Kelly SM, Koeppen H, Hart J, Rubin CM, Thistlethwaite JR Jr.

Transplantation. 1996 Aug 15;62(3):370-5.

PMID:
8779685
[PubMed - indexed for MEDLINE]
12.

Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.

Praghakaran K, Wise B, Chen A, Schwarz K, Colombani P.

J Pediatr Surg. 1999 Jan;34(1):112-5; discussion 115-6.

PMID:
10022154
[PubMed - indexed for MEDLINE]
13.

Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression.

Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML.

Transplantation. 1999 Oct 15;68(7):997-1003.

PMID:
10532541
[PubMed - indexed for MEDLINE]
14.

Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.

Serinet MO, Jacquemin E, Habes D, Debray D, Fabre M, Bernard O.

J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):389-93.

PMID:
11930095
[PubMed - indexed for MEDLINE]
15.

Management and outcome of liver recipients with post-transplant lymphoproliferative disease.

Glez-Chamorro A, Jimenez C, Moreno-Glez E, Glez-Pinto I, Loinaz C, Gomez R, Garcia I, Alonso O, Palma F, Grande C.

Hepatogastroenterology. 2000 Jan-Feb;47(31):211-9.

PMID:
10690611
[PubMed - indexed for MEDLINE]
16.

Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.

Davis CL, Harrison KL, McVicar JP, Forg PJ, Bronner MP, Marsh CL.

Clin Transplant. 1995 Feb;9(1):53-9.

PMID:
7742583
[PubMed - indexed for MEDLINE]
17.

Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.

Wasson S, Zafar MN, Best J, Reddy HK.

J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):77-83.

PMID:
16703222
[PubMed - indexed for MEDLINE]
18.

Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients.

Roque J, Rios G, Humeres R, Volpi C, Herrera JM, Schultz M, Rios H, Rius M, Salgado C, Hepp J.

Transplant Proc. 2006 Apr;38(3):930-1.

PMID:
16647513
[PubMed - indexed for MEDLINE]
19.

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.

Lee TC, Savoldo B, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Barshes NR, Scott JD, Bristow LJ, O'Mahony CA, Goss JA.

Am J Transplant. 2005 Sep;5(9):2222-8.

PMID:
16095501
[PubMed - indexed for MEDLINE]
Free Article
20.

Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.

Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.

Transplantation. 2009 Mar 15;87(5):758-62. doi: 10.1097/TP.0b013e318198d645.

PMID:
19295323
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk